Agency Business briefs

Share this article:
GSW Worldwide has absorbed inVentiv Health sibling Stonefly Communications Group. The shop will bring retail and consumer packaged goods expertise to GSW, said inVentiv. Clients include Abbott Nutrition, Endo, Health Mart pharmacies and P&G. Stonefly president and CEO John Racik will become group president of strategic business teams for GSW Worldwide, serving on the network's executive leadership team.

DDB New York and Tribal DDB New York launched DDB Remedy, a professional healthcare shop led by Larry Lannino and John Kelly, who will report into global business director for DDB New York Ellen Fields. DDB uses the Remedy brand in other markets outside the US. Lannino was previously managing partner at Sudler & Hennessey, while Kelly was SVP, associate creative director at Euro.

Porter Novelli named chief medical officer Barbara DeBuono, MD to lead its global healthcare practice. DeBuono becomes global director of health and social marketing, charged with overseeing development, with a focus on the convergence of advocacy, issues, policy, digital and social marketing. She will also head the firm's New York practice and reports to Julie Winskie.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?